Earlier Use of Acalabrutinib Associated With Improved Survival in CLL
CAR T-Cell Therapy Is Safe, Feasible in Outpatient Setting for NHL
Ponatinib Regimen Shows Long-term Efficacy in Acute Lymphoblastic Leukemia
Englumafusp alfa/Glofitamab Combo Shows Early Responses in R/R Aggressive non-Hodgkin Lymphoma